Login / Signup

Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial.

Cosima LocherSarah BuerglerAntje Frey NascimentoLinda KostCharlotte BleaseJens Gaab
Published in: BMJ open (2021)
NCT02578420.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • study protocol
  • phase ii study
  • double blind
  • placebo controlled
  • squamous cell carcinoma